Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 29 studies | 79% ± 13% | |
endothelial cell | 15 studies | 28% ± 13% | |
vein endothelial cell | 10 studies | 35% ± 13% | |
platelet | 6 studies | 28% ± 15% | |
hematopoietic stem cell | 4 studies | 29% ± 8% | |
endothelial cell of sinusoid | 3 studies | 29% ± 18% | |
megakaryocyte | 3 studies | 58% ± 14% |
Insufficient scRNA-seq data for expression of MMRN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 3070.21 | 566 / 578 | 78% | 4.44 | 896 / 1155 |
thymus | 99% | 6442.94 | 648 / 653 | 66% | 3.07 | 400 / 605 |
esophagus | 92% | 1752.16 | 1336 / 1445 | 58% | 3.41 | 107 / 183 |
breast | 88% | 3962.07 | 402 / 459 | 63% | 4.11 | 699 / 1118 |
uterus | 98% | 2906.48 | 167 / 170 | 52% | 2.46 | 238 / 459 |
prostate | 64% | 952.08 | 157 / 245 | 79% | 3.73 | 399 / 502 |
intestine | 92% | 2501.53 | 893 / 966 | 50% | 2.66 | 262 / 527 |
bladder | 95% | 1702.76 | 20 / 21 | 42% | 1.61 | 211 / 504 |
stomach | 60% | 1079.56 | 216 / 359 | 57% | 2.64 | 162 / 286 |
skin | 64% | 1304.23 | 1156 / 1809 | 38% | 2.18 | 177 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.54 | 1 / 1 |
pancreas | 12% | 90.43 | 40 / 328 | 87% | 9.48 | 154 / 178 |
adipose | 96% | 4167.14 | 1150 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 31% | 246.71 | 79 / 258 | 59% | 3.20 | 136 / 230 |
ovary | 54% | 1163.06 | 98 / 180 | 27% | 0.91 | 117 / 430 |
liver | 27% | 259.31 | 61 / 226 | 46% | 1.38 | 188 / 406 |
kidney | 9% | 97.84 | 8 / 89 | 64% | 7.18 | 576 / 901 |
blood vessel | 72% | 1790.16 | 966 / 1335 | 0% | 0 | 0 / 0 |
brain | 3% | 24.79 | 79 / 2642 | 69% | 3.00 | 488 / 705 |
lymph node | 0% | 0 | 0 / 0 | 69% | 4.02 | 20 / 29 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.78 | 23 / 45 |
eye | 0% | 0 | 0 / 0 | 35% | 0.61 | 28 / 80 |
heart | 31% | 337.93 | 268 / 861 | 0% | 0 | 0 / 0 |
muscle | 9% | 70.53 | 70 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 44.16 | 56 / 929 | 0% | 0 | 0 / 0 |
spleen | 5% | 40.14 | 11 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0007155 | Biological process | cell adhesion |
GO_0007596 | Biological process | blood coagulation |
GO_0061045 | Biological process | negative regulation of wound healing |
GO_1901731 | Biological process | positive regulation of platelet aggregation |
GO_1990972 | Cellular component | multimerin complex |
GO_0031091 | Cellular component | platelet alpha granule |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MMRN1 |
Protein name | Multimerin 1 Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4) (Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin (p-155) (p155)] |
Synonyms | EMILIN4 ECM MMRN GPIA* |
Description | FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. . |
Accessions | ENST00000264790.7 [Q13201-1] ENST00000394980.5 [Q13201-1] Q13201 E7EPG1 ENST00000508372.1 |